With weight loss drugs taking the world by storm, more people are exploring adding these medical marvels to their toolkits.
Clinical trials show retatrutide, Eli Lilly's new triple-agonist drug, delivered 24.2% weight loss in 48 weeks and the ...
New weight-loss drugs in the works will offer more choices beyond GLP-1 options Wegovy and Zepbound. What to know about ...
GLP-1 weight-loss pills appear to be just as effective as injections, with clinical trials showing similar average weight ...
As many as 12% of Americans are currently using GLP-1 medications such as Ozempic and Wegovy, according to one estimate.
A University of Oxford study published in The BMJ finds users of GLP-1 drugs like Ozempic regain weight and reverse heart ...
GLP-1 medications can create opportunity for change—but environment determines what lasts. Discover how context shapes habits ...
University Hospitals cardiologist explains the benefits, side effects, and future of these increasingly popular drugs.
As the GLP-1 trend expands, a 'halo effect' is developing. Consumers in families of GLP-1 users are increasingly eating GLP-1 ...
Microdosing GLP-1 weight loss drugs like semaglutide is trendy, with supporters touting benefits such as lower costs and potentially fewer side effects. But some doctors are skeptical, calling it ...
I’m a dietitian, and I’ve been taking a GLP-1 for close to four years. People often ask why someone who specializes in ...
Retailer offerings trumpet a variety of claims about protein, fat and fibre levels, while some seem to simply be smaller ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results